Our bankers and specialists focus on solutions for life sciences companies at all stages—from startups to established businesses, pre-clinical through commercialization. We have decades of experience in the sector and understand the complex financial and regulatory challenges you face. We bring a wealth of expertise and insights to the venture capital space, and we’re ready to help you stay positioned for innovation and growth.
We can provide a simple, secure and scalable connection to what you need, when you need it—whether it’s day-to-day credit, financing, treasury and payments or support of international expansion. We also partner across J.P. Morgan’s lines of business, including Investment Banking, Private Banking and Asset Management, to build a full financial ecosystem around the industry.
We can be where you need us to be. With offices and experts around the world, we can help your life sciences company navigate the complexities of expanding and maintaining international operations.
We know no two life sciences companies are the same. That’s why our team goes below the surface to support the unique needs of industry subsectors, including biotechnology, biopharmaceuticals, pharmaceuticals, medical devices, medical tools and diagnostics, and CROs, CDMOs and CMOs.
Our clients also gain access to vital industry insights from the annual J.P. Morgan Healthcare Conference, along with the rich analysis and research of J.P. Morgan Markets.
Fast-growing companies like yours need products that meet your needs today and evolve with you tomorrow. With smooth onboarding and an intuitive digital experience, you’ll be able to reduce costs, save time and make more informed decisions so that you can get back to growing your business.
Chase Cashflow360SM
Connect digitally with suppliers and clients to automate invoicing, payments, approvals and reconciliation–all within Chase Connect
Multiple payment solutions to help meet the needs of your organization and employees.
Address global challenges with strategic solutions, insights and market perspective.
Monitor and control your cash to optimize returns across your entities, geographies and currencies.
World-class investment experts with local expertise and global solutions.
Get in touch
Hide
Get in touch
Hide
Outlook
Oct 29, 2024
Our Biopharma and Medtech Licensing and Venture Reports explore upfront cash, mergers, acquisitions and other trends seen in the third quarter of 2024.
Read moreBanking
Oct 24, 2024
View our guide to raising capital for your startup to learn about funding options for early and growth stages and tips for attracting investors.
Read moreBanking
Oct 17, 2024
Learn about venture debt, including its advantages and what founders should consider before taking on venture debt.
Read more